SARS-CoV-2-INDUCED MICROSCOPIC POLYANGIITIS: CLINICAL PROBLEM
Introduction. During the COVID-19 pandemic, the diagnosis and treatment of ANCA-associated vasculitis (AAV) have been discussed in different ways. At the same time, the authors of many foreign publications state that SARS-CoV-2 infection can be another viral trigger for the development of AAV in chi...
Saved in:
| Main Authors: | Olga O. Gutsalenko, Borys M. Fylenko, Tetyana I. Yarmola, Nataliia V. Roiko, Iryna V. Tsyganenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department
2025-05-01
|
| Series: | Клінічна та профілактична медицина |
| Subjects: | |
| Online Access: | https://cp-medical.com/index.php/journal/article/view/599 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01) -
Livedo racemosa as the presenting symptom of microscopic polyangiitis
by: Christine Li, BS, et al.
Published: (2025-09-01) -
Granulomаtosis With Polyangiitis Affecting the Lung and Orbit
by: Zh. V. Sheikh, et al.
Published: (2021-06-01) -
Avacopan is effective in inducing remission for MPA/GPA, regardless of changes in serum C5a levels: a single-center study in Japan
by: Yusuke Ushio, et al.
Published: (2025-08-01) -
Efficiency of using rituximab in a patient with generalized granulomatosis with polyangiitis: A case report
by: Gulazyk Malikovna Koilubaeva, et al.
Published: (2014-12-01)